21.09.2012

Phase-I-studies with newly developed liposomal formulations: safety and efficacy issues

Dr. Barbara Schug, SocraTec R&D GmbH
AGAH Workshop on liposomal formulations, Bonn

 
Menu

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
All fine on single presentations